Influenza is a highly contagious, acute, febrile respiratory illness caused by influenza
A and B viruses. These viruses undergo rapid antigenic change and cause annual or
near-annual seasonal epidemics of febrile respiratory disease affecting all age groups.
In addition, influenza A viruses infrequently initiate explosive global epidemics
of disease known as pandemics.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).Morbid Mortal Weekly Rep. 2001; 50: 1-63
- Influenza-associated morbidity and mortality in young and middle-aged women.JAMA. 1999; 281: 901-907
- Orthomyxoviruses: Influenza.in: Collier L Sussman M Balows A Topley & Wilson's Microbiology & Microbial Infections. 9th edition. Edward Arnold Publishing, London1998
- An introduction to the work of William Farr.Am J Epidemiol. 1975; 101: 469-476
- Epidemiological and clinical aspects of influenza.in: Beare A.S Basic and applied influenza research. CRC Press, Boca Raton (FL)1982: 12-50
- Orthomyxoviruses.in: Fields B.N Virology. 2nd edition. Raven Press, New York1990: 1091-1152
- Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics.J Virol. 1989; 63: 4603-4608
- Initial genetic characterization of the 1918 “Spanish” influenza virus.Science. 1997; 275: 1793-1796
- Characterization of an avian influenza A (H5N1) virus isolated from a child with fatal respiratory illness.Science. 1998; 279: 393-396
- Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.Lancet. 1998; 351: 467-471
- Influenza.in: Mandell G.L Bennett J.E Dolin R Principles and practice of infectious diseases. 5th edition. Churchill Livingstone, Philadelphia2000: 1823-1849
- Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.Arch Intern Med. 2001; 161: 2116-2122
- The pathophysiology of influenza pneumonia in 1918.Perspect Biol Med. 1981; 25: 115-125
- Influenza virus and neurological diseases.Psychiatry Clin Neurosci. 1997; 51: 181-184
- Toxic shock syndrome complicating influenza A infection: a two-case report with one case of bacteremia and endocarditis.Intensive Care Med. 2001; 27: 443
- PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis.Lancet. 1998; 352: 873-875
- Influenza A-associated encephalopathy with bilateral thalamic necrosis in Japan.Clin Infect Dis. 2000; 31: 611-613
- Epidemiology of influenza-associated encephalitis-encephalopathy in Hokkaido, the northernmost island of Japan.Pediatr Int. 2000; 42: 192-196
- Rapid detection of respiratory syncitial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies.J Clin Microbiol. 1990; 28: 1159-1162
- Rapid detection of influenza virus by shell vial assay with monoclonal antibodies.J Clin Microbiol. 1986; 24: 677-679
- Rapid diagnosis of influenza A infection by direct immunofluorescence of nasopharyngeal aspirates in adults.J Clin Microbiol. 1979; 9: 688-692
- Medical Letter. Rapid diagnostic tests for influenza.Med Lett Drugs Ther. 1999; 41: 121-122
- Comparison of Directogen Flu-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus.J Clin Microbiol. 1991; 29: 479-482
- Current research on influenza and other respiratory viruses: II. International symposium.Antiviral Res. 2000; 46: 91-124
- Etiologic diagnosis of influenza A virus by enzymatic radioimmunoassay.J Clin Microbiol. 1984; 19: 361-365
- Time-resolved fluoroimmunoassay with monoclonal antibodies for rapid diagnosis of influenza infections.J Clin Microbiol. 1986; 24: 907-912
- Enzyme immunoassay for direct detection of influenza type A and adenovirus antigens in clinical specimens.J Clin Microbiol. 1982; 15: 5-11
- Multiplex PCR for typing and subtyping influenza and respiratory syncitial viruses.J Clin Microbiol. 1998; 36: 2990-2995
- Comparison of multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens.J Clin Micro. 2001; 39: 2779-2783
- Evaluation of the Hexaplex assay for detection of respiratory viruses in children.J Clin Micro. 2001; 39: 1696-1701
- Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza virus A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription—polymerase chain reaction—enzyme hybridization assay (Hexaplex).Clin Inf Dis. 1998; 26: 1397-1402
- The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.N Engl J Med. 1994; 331: 778-784
- Inactivated influenza vaccines.in: Plotkin M Orenstein W Vaccines. 3rd edition. Harcourt, Philadelphia1999: 531-552
- Influenza vaccines: A reappraisal of their use.Drugs. 1997; 54: 841-856
- Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization.Ann Intern Med. 1994; 121: 947-952
- Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.Arch Intern Med. 1998; 158: 1769-1776
- Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic.JAMA. 1985; 253: 1136-1139
- Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes.in: Kendal A Patriarca P Options for the control of influenza. Alan R. Liss, Inc, New York1986: 155-168
- Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents.Vaccine. 2001; 19: 308-318
- Guillain–Barré syndrome.N Engl J Med. 1992; 326: 1130-1136
- Reassessment of the association between Guillain–Barré syndrome and receipt of swine influenza vaccine in 1976–1977: results of a two-state study. Expert Neurology Group.Am J Epidemiol. 1991; 133: 940-951
- Guillain–Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977.Am J Epidemiol. 1979; 110: 105-123
- The Guillain–Barré syndrome and the 1992–1993 and 1993–1994 influenza vaccines.N Engl J Med. 1998; 339: 1797-1802
- Investigation of a possible association between influenza vaccination and Guillain–Barré syndrome in the United States, 1990–1991.Post Marketing Surveillance. 1992; 6 ([abstract 040]): 5-6
- Guillain–Barré syndrome and the 1978–1979 influenza vaccine.N Engl J Med. 1981; 304: 1557-1561
- Guillain–Barré syndrome in the United States, 1979–1980 and 1980–1981.JAMA. 1982; 248: 698-700
- Prophylaxis and treatment of influenza.N Engl J Med. 1990; 322: 443-450
- Neuraminidase inhibitors for treatment of influenza A and B infections.Morbid Mortal Weekly Rep. 1999; 48
- Prevention and early treatment of influenza in healthy adults.Vaccine. 2000; 18: 957-1030
- Emergence and apparent transmission of rimantidine-resistant influenza A virus in families.N Engl J Med. 1989; 321: 1696-1702
- Implications of viral resistance to amantadine in control of influenza A.Clin Infect Dis. 1992; 15: 362-367
- Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial.JAMA. 2000; 283: 1016-1024
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial.Lancet. 2000; 355: 1845-1850
- Efficacy and safety of the neuraminadase inhibitor zanamivir in the treatment of influenzavirus infections.N Engl J Med. 1997; 337: 874-880
- Randomized trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B infections.Lancet. 1998; 352: 1877-1881
- Revised labeling for zanamivir.JAMA. 2000; 284: 1234
- Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.J Infect Dis. 1998; 178: 1257-1262
- Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.J Infect Dis. 2001; 183: 523-531
Article info
Identification
Copyright
© 2002 Elsevier Science (USA). Published by Elsevier Inc. All rights reserved.
